Novel drug targets in clinical development for heart failure.
about
Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter TrialDeveloping Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials?Prediction model of in-hospital mortality in elderly patients with acute heart failure based on retrospective study.
P2860
Novel drug targets in clinical development for heart failure.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel drug targets in clinical development for heart failure.
@en
type
label
Novel drug targets in clinical development for heart failure.
@en
prefLabel
Novel drug targets in clinical development for heart failure.
@en
P2093
P2860
P1476
Novel drug targets in clinical development for heart failure
@en
P2093
Elangovan Shanmugam
Muthukumar Rajaram
Thangavel Mahalingam VijayaKumar
P2860
P2888
P304
P356
10.1007/S00228-014-1671-4
P577
2014-04-09T00:00:00Z
P6179
1030236637